• Buchholz K, Comini MA, Wissenbach D et al. (2008) Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products. Molecular & Biochemical Parasitology 160, 6569.
  • Ferreira C (1893) Sur l′emploi du bleu de méthylène dans la malaria infantile. Revue de Thérapeutique Médico-Chirurgicale 124, 488525.
  • Greenwood BM, Bojang K, Whitty CJ & Targett GA (2005) Malaria. Lancet 365, 14871498.
  • International Artemisinin Study Group (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 917.
  • Kouyate B, Sie A, Ye M, De AM & Müller O (2007) The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS Medicine 4, e127.
  • Mandi G, Witte S, Meissner P et al. (2005) Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Tropical Medicine and International Health 10, 3238.
  • Meissner PE, Mandi G, Witte S et al. (2005) Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. Malaria Journal 4, 45.
  • Meissner PE, Mandi G, Coulibaly B et al. (2006) Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malaria Journal 5, 84.
  • Müller O, Boele vam Hensbroek M, Jaffar S et al. (1996) A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria. Tropical Medicine and International Health 1, 124132.
  • Müller O, Becher H, van Zweeden AB et al. (2001) Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled. BMJ 322, 1567.
  • Schirmer RH, Coulibaly B & Stich A (2003) Methylene blue in the treatment of malaria – past and presence. Redox Report 8, 272276.
  • Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369374.
  • Sokhna CS, Rogier C, Dieye A & Trape JF (2000) Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. American Journal of Tropical Medicine and Hygiene 62, 266270.
  • Walter-Sack I, Rengelshausen J, Oberwittler H et al. (2009) High absolute bioavailability of methylene blue given as an aqueous oral formulation. European Journal of Clinical Pharmacology 65, 179189.
  • WHO (2003) Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO/HTM/RBM/2003.50.
  • Zoungrana A, Coulibaly B, Sie A et al. (2008) Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS ONE 3, e1630.